Patents Assigned to THE FACULTY OF MEDICINE OF THE UNIV. OF GENEVA
  • ANTIBODIES SPECIFICALLY REACTIVE WITH A TUMOR NECROSIS FACTOR RELATED LIGAND
    Publication number: 20100260761
    Abstract: The present invention relates to antibodies that bind Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.
    Type: Application
    Filed: June 5, 2006
    Publication date: October 14, 2010
    Applicants: BIOGEN, INC., THE FACULTY OF MEDICINE OF THE UNIV. OF GENEVA
    Inventors: Jeffrey Browning, Yves Chicheportiche